Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients.

Anaïs HérivauxJesse R WillisToine MercierKatrien LagrouSamuel M GonçalvesRelber A GonçalesJohan MaertensAgostinho CarvalhoToni GabaldónCristina Cunha

Published in: Thorax (2021)

Our results reveal the lung microbiota as an understudied source of clinical variation in patients at risk of IPA and highlight its potential as a diagnostic and therapeutic target in the context of respiratory fungal diseases.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
single cell
genome wide
patient reported outcomes